Drug Profile
KF 17828
Latest Information Update: 26 May 2001
Price :
$50
*
At a glance
- Originator Kyowa Hakko
- Class Antihyperlipidaemics; Dibenzoxepins; Small molecules
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercholesterolaemia
Most Recent Events
- 26 May 2001 Discontinued-Preclinical for Hypercholesterolaemia in Japan (Unknown route)
- 16 Feb 1995 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)